A Light-Controlled DNA Nanoclaw Machine: Integrated Multiplexed Recognition, Spatiotemporally Programmable Therapy, and Real-Time Electrochemical Signaling for Precision Receptor Regulation
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c03110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Xia Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an710061, China. Hauptthemen laut MEDLINE: DNA Nanostructures, Electrochemical Techniques, Mucin-1, Epithelial Cell Adhesion Molecule. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cell membrane receptors are pivotal targets in precise therapeutics, yet their ubiquitous expression across tissues remains a fundamental barrier to achieving cell-specific intervention. To overcome the limitations of conventional monotargeting approaches, we developed a light-gated DNA nanoclaw machine (L-DNM) that integrates high-specificity recognition, spatiotemporally controlled therapy, and real-time monitoring of molecular activation within a unified nanoplatform. The L-DNM employed a multivalent targeting mechanism directed against a triple-marker signature, epithelial cell adhesion molecule (EpCAM), MUC1, and nucleolin (NCL), achieving exceptional targeting accuracy toward MCF-7 human breast cancer cells even in heterogeneous environments. Its novel photocleavable aptamer design ensures that the Met-inhibiting function remains biologically inert until activated by UV irradiation. This strategy enables precise spatiotemporal control over receptor tyrosine kinase (RTK) inhibition with minimal off-target effects. Furthermore, the system couples therapeutic activation with instantaneous electrochemiluminescence (ECL) reporting, transforming molecular recognition events into quantifiable signals with high signal-to-noise ratio in complex matrices. By unifying multiplexed targeting, light-gated activation, and self-reporting capability, the L-DNM platform represents a transformative shift from conventional therapeutics to adaptive, intelligent theranostic systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an710061, China.
- Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis, Xi'an710061, China.
- Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education, Xi'an710061, China.
ORCID-Profile: Xiaoyu Xie
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Zhao, Y., Xia, G., Zhang, M., Wang, J., Bu, Y., & Xie, X. (2026). A Light-Controlled DNA Nanoclaw Machine: Integrated Multiplexed Recognition, Spatiotemporally Programmable Therapy, and Real-Time Electrochemical Signaling for Precision Receptor Regulation. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c03110
Vancouver
Liu X, Zhao Y, Xia G, Zhang M, Wang J, Bu Y, et al. A Light-Controlled DNA Nanoclaw Machine: Integrated Multiplexed Recognition, Spatiotemporally Programmable Therapy, and Real-Time Electrochemical Signaling for Precision Receptor Regulation. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c03110
BibTeX
@article{Liu2026,
author = {Liu, Xia and Zhao, Ying and Xia, Guoxi and Zhang, Minglei and Wang, Jiabo and Bu, Yusi and Xie, Xiaoyu},
title = {A Light-Controlled DNA Nanoclaw Machine: Integrated Multiplexed Recognition, Spatiotemporally Programmable Therapy, and Real-Time Electrochemical Signaling for Precision Receptor Regulation},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c03110}
}
EUVIMED